These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study. Sweet RA; Bennett DA; Graff-Radford NR; Mayeux R; Brain; 2010 Apr; 133(Pt 4):1155-62. PubMed ID: 20147454 [TBL] [Abstract][Full Text] [Related]
29. [Psychotic symptoms and Alzheimer's disease]. Alberca R; Gil-Néciga E; Salas D; Pérez JA; Lozano P Neurologia; 2000 Jan; 15(1):8-14. PubMed ID: 10730061 [TBL] [Abstract][Full Text] [Related]
30. Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus. Kales HC; Lyketsos CG; Miller EM; Ballard C Int Psychogeriatr; 2019 Jan; 31(1):83-90. PubMed ID: 30068400 [TBL] [Abstract][Full Text] [Related]
31. Cerebrospinal Fluid Correlates of Neuropsychiatric Symptoms in Patients with Alzheimer's Disease/Mild Cognitive Impairment: A Systematic Review. Showraki A; Murari G; Ismail Z; Barfett JJ; Fornazzari L; Munoz DG; Schweizer TA; Fischer CE J Alzheimers Dis; 2019; 71(2):477-501. PubMed ID: 31424398 [TBL] [Abstract][Full Text] [Related]
32. Pimavanserin in Alzheimer's Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms. Ballard C; Youakim JM; Coate B; Stankovic S J Prev Alzheimers Dis; 2019; 6(1):27-33. PubMed ID: 30569083 [TBL] [Abstract][Full Text] [Related]
34. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic. Shea YF; Ha J; Chu LW Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477 [TBL] [Abstract][Full Text] [Related]
35. Grouping and trajectories of the neuropsychiatric symptoms in patients with Alzheimer's disease, part I: symptom clusters. Garre-Olmo J; López-Pousa S; Vilalta-Franch J; de Gracia Blanco M; Vilarrasa AB J Alzheimers Dis; 2010; 22(4):1157-67. PubMed ID: 20930289 [TBL] [Abstract][Full Text] [Related]
36. Gray matter volumes and treatment response of psychotic symptoms to risperidone in antipsychotic-naïve Alzheimer's disease patients. Lee YM; Park JM; Lee BD; Moon E; Jeong HJ; Chung YI; Kim JH; Kim HJ; Mun CW; Kim TH; Kim YH J Clin Psychiatry; 2016 Jan; 77(1):e8-13. PubMed ID: 26845282 [TBL] [Abstract][Full Text] [Related]
37. A Bayesian model of psychosis symptom trajectory in Alzheimer's disease. Seltman HJ; Mitchell S; Sweet RA Int J Geriatr Psychiatry; 2016 Feb; 31(2):204-10. PubMed ID: 26216660 [TBL] [Abstract][Full Text] [Related]
38. Clinical variables associated with psychosis in Alzheimer's disease. Kotrla KJ; Chacko RC; Harper RG; Doody R Am J Psychiatry; 1995 Sep; 152(9):1377-9. PubMed ID: 7653698 [TBL] [Abstract][Full Text] [Related]
39. Alzheimer disease subjects with psychosis have increased schizotypal symptoms before dementia onset. Eror EA; Lopez OL; Dekosky ST; Sweet RA Biol Psychiatry; 2005 Aug; 58(4):325-30. PubMed ID: 15978552 [TBL] [Abstract][Full Text] [Related]
40. Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects. Dietlin S; Soto M; Kiyasova V; Pueyo M; de Mauleon A; Delrieu J; Ousset PJ; Vellas B J Alzheimers Dis; 2019; 70(1):25-34. PubMed ID: 31127783 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]